NeuPath Health Inc. (TSXV:NPTH)
Canada · Delayed Price · Currency is CAD 0.6300
+0.0400 (6.78%)
At close: Jun 1, 2026
NeuPath Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 89.37 | 87.19 | 72.81 | 66.1 | 62.65 | 60.86 |
| 89.37 | 87.19 | 72.81 | 66.1 | 62.65 | 60.86 | |
Revenue Growth (YoY) | 19.71% | 19.76% | 10.14% | 5.50% | 2.95% | 27.74% |
Cost of Revenue | 72.46 | 70.6 | 58.95 | 53.81 | 51.83 | 49.8 |
Gross Profit | 16.91 | 16.59 | 13.86 | 12.3 | 10.82 | 11.06 |
Selling, General & Admin | 12.23 | 12.27 | 10.15 | 9.25 | 9.41 | 9.95 |
Operating Expenses | 14.47 | 14.56 | 12.45 | 11.86 | 12.08 | 12.97 |
Operating Income | 2.44 | 2.04 | 1.41 | 0.44 | -1.26 | -1.91 |
Interest Expense | -0.79 | -0.9 | -0.95 | -0.93 | -0.83 | -0.88 |
Interest & Investment Income | - | - | - | 0.01 | 0.02 | 0.03 |
EBT Excluding Unusual Items | 1.66 | 1.14 | 0.46 | -0.48 | -2.07 | -2.76 |
Merger & Restructuring Charges | -1.05 | -1.2 | -0.72 | -0.23 | -0.58 | -0.56 |
Gain (Loss) on Sale of Assets | - | - | -0.02 | 0.76 | - | - |
Asset Writedown | - | - | - | - | -1.94 | - |
Other Unusual Items | - | - | - | - | 0.5 | 0.07 |
Pretax Income | 0.61 | -0.06 | -0.27 | 0.06 | -4.08 | -3.25 |
Income Tax Expense | 0.31 | 0.36 | 0.21 | 0.25 | 0.19 | -0.02 |
Earnings From Continuing Operations | 0.29 | -0.41 | -0.49 | -0.19 | -4.28 | -3.23 |
Minority Interest in Earnings | -0.28 | -0.3 | -0.24 | 0.08 | 0.13 | - |
Net Income | 0.01 | -0.72 | -0.73 | -0.11 | -4.14 | -3.23 |
Net Income to Common | 0.01 | -0.72 | -0.73 | -0.11 | -4.14 | -3.23 |
Shares Outstanding (Basic) | 56 | 56 | 56 | 55 | 48 | 45 |
Shares Outstanding (Diluted) | 59 | 59 | 57 | 55 | 48 | 45 |
Shares Change (YoY) | 5.35% | 2.40% | 3.54% | 14.44% | 7.40% | 84.24% |
EPS (Basic) | 0.00 | -0.01 | -0.01 | -0.00 | -0.09 | -0.07 |
EPS (Diluted) | 0.00 | -0.01 | -0.01 | -0.00 | -0.09 | -0.07 |
Free Cash Flow | 1.56 | 3.29 | 1.66 | 2.68 | -0.49 | 1.51 |
Free Cash Flow Per Share | 0.03 | 0.06 | 0.03 | 0.05 | -0.01 | 0.03 |
Gross Margin | 18.92% | 19.03% | 19.03% | 18.60% | 17.27% | 18.17% |
Operating Margin | 2.73% | 2.33% | 1.93% | 0.67% | -2.00% | -3.14% |
Profit Margin | 0.01% | -0.82% | -1.00% | -0.16% | -6.61% | -5.31% |
Free Cash Flow Margin | 1.74% | 3.77% | 2.28% | 4.05% | -0.79% | 2.48% |
EBITDA | 3.4 | 3.04 | 2.43 | 1.62 | -0.17 | -0.26 |
EBITDA Margin | 3.80% | 3.49% | 3.33% | 2.45% | -0.27% | -0.43% |
D&A For EBITDA | 0.95 | 1.01 | 1.02 | 1.18 | 1.08 | 1.65 |
EBIT | 2.44 | 2.04 | 1.41 | 0.44 | -1.26 | -1.91 |
EBIT Margin | 2.73% | 2.33% | 1.93% | 0.67% | -2.00% | -3.14% |
Effective Tax Rate | 51.57% | - | - | 447.27% | - | - |
Revenue as Reported | 89.37 | 87.19 | 72.81 | 66.1 | 62.65 | 60.86 |